1. Home
  2. ABVX vs NNN Comparison

ABVX vs NNN Comparison

Compare ABVX & NNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • NNN
  • Stock Information
  • Founded
  • ABVX 2013
  • NNN 1984
  • Country
  • ABVX France
  • NNN United States
  • Employees
  • ABVX N/A
  • NNN N/A
  • Industry
  • ABVX
  • NNN Real Estate Investment Trusts
  • Sector
  • ABVX
  • NNN Real Estate
  • Exchange
  • ABVX Nasdaq
  • NNN Nasdaq
  • Market Cap
  • ABVX 6.7B
  • NNN 7.8B
  • IPO Year
  • ABVX N/A
  • NNN N/A
  • Fundamental
  • Price
  • ABVX $90.65
  • NNN $41.99
  • Analyst Decision
  • ABVX Strong Buy
  • NNN Hold
  • Analyst Count
  • ABVX 9
  • NNN 8
  • Target Price
  • ABVX $94.11
  • NNN $44.29
  • AVG Volume (30 Days)
  • ABVX 957.6K
  • NNN 1.2M
  • Earning Date
  • ABVX 08-11-2025
  • NNN 11-04-2025
  • Dividend Yield
  • ABVX N/A
  • NNN 5.72%
  • EPS Growth
  • ABVX N/A
  • NNN N/A
  • EPS
  • ABVX N/A
  • NNN 2.10
  • Revenue
  • ABVX $7,073,400.00
  • NNN $894,702,000.00
  • Revenue This Year
  • ABVX $4.44
  • NNN $5.26
  • Revenue Next Year
  • ABVX N/A
  • NNN $4.00
  • P/E Ratio
  • ABVX N/A
  • NNN $19.98
  • Revenue Growth
  • ABVX N/A
  • NNN 4.82
  • 52 Week Low
  • ABVX $4.77
  • NNN $35.80
  • 52 Week High
  • ABVX $93.77
  • NNN $49.57
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 74.86
  • NNN 44.22
  • Support Level
  • ABVX $85.00
  • NNN $42.43
  • Resistance Level
  • ABVX $90.70
  • NNN $43.39
  • Average True Range (ATR)
  • ABVX 2.98
  • NNN 0.51
  • MACD
  • ABVX -0.26
  • NNN -0.06
  • Stochastic Oscillator
  • ABVX 75.33
  • NNN 14.89

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

About NNN NNN REIT Inc.

NNN REIT Inc is a real estate investment trust that invests in and develops properties throughout the United States. The company generates revenue from leasing properties to tenants, including convenience stores, automotive services, fitness centers, theatres, restaurants, and banks. Rents from convenience stores and restaurants contribute the majority proportion of total revenue. The maximum of the company's properties are located in the South and Southeast of the United States.

Share on Social Networks: